Bionano Genomics, Inc. Banner Image

Bionano Genomics, Inc.

  • Ticker BNGO
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Bionano Genomics, Inc. Logo Image
  • 201-500 Employees
  • Based in San Diego, California
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specificMore structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
4.7 / 5.0 (152)

Bionano Genomics, Inc. reports have an aggregate usefulness score of 4.7 based on 152 reviews.

Bionano Genomics, Inc.

Most Recent Annual Report

Bionano Genomics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Bionano Genomics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!